UiPath (NASDAQ:PATH) Updates Q2 2022 Earnings Guidance

UiPath (NASDAQ:PATH) issued an update on its second quarter 2022 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $180 million-185 million.

Shares of PATH stock opened at $74.03 on Friday. The company has a 50-day moving average price of $56.76. UiPath has a twelve month low of $61.50 and a twelve month high of $90.00.

UiPath (NASDAQ:PATH) last announced its earnings results on Monday, June 7th. The healthcare company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.07.

PATH has been the subject of several recent analyst reports. Canaccord Genuity restated a hold rating and issued a $75.00 price target (up previously from $70.00) on shares of UiPath in a report on Wednesday. They noted that the move was a valuation call. DA Davidson initiated coverage on UiPath in a report on Monday, May 17th. They issued a buy rating and a $85.00 price target for the company. BMO Capital Markets lifted their price target on UiPath from $80.00 to $85.00 and gave the company a market perform rating in a report on Wednesday. Royal Bank of Canada initiated coverage on UiPath in a report on Monday, May 17th. They issued a sector perform rating and a $74.00 price target for the company. Finally, Cowen initiated coverage on UiPath in a report on Monday, May 17th. They issued an outperform rating and a $82.00 price target for the company. Eleven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $76.89.

In related news, major shareholder East Fund 2013 Sca Sic Digital sold 2,100,400 shares of the business’s stock in a transaction that occurred on Friday, April 23rd. The stock was sold at an average price of $56.00, for a total transaction of $117,622,400.00. Also, CEO Daniel Dines sold 1,383,168 shares of the company’s stock in a transaction that occurred on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total value of $77,457,408.00. Insiders have sold a total of 5,011,241 shares of company stock worth $280,629,496 over the last three months.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.

Further Reading: Special Dividends

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.